766 related articles for article (PubMed ID: 13680381)
1. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
Heger S; Partsch CJ; Sippell WG
J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723
[TBL] [Abstract][Full Text] [Related]
3. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
Antoniazzi F; Zamboni G; Bertoldo F; Lauriola S; Mengarda F; Pietrobelli A; Tatò L
J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090
[TBL] [Abstract][Full Text] [Related]
4. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution.
van den Bergh JP; Hermus AR; Spruyt AI; Sweep CG; Corstens FH; Smals AG
Osteoporos Int; 2001; 12(1):55-62. PubMed ID: 11305084
[TBL] [Abstract][Full Text] [Related]
6. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
[TBL] [Abstract][Full Text] [Related]
9. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
Bertelloni S; Baroncelli GI; Ferdeghini M; Menchini-Fabris F; Saggese G
Eur J Pediatr; 2000 May; 159(5):369-74. PubMed ID: 10834524
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy.
Sahota O; San P; Cawte SA; Pearson D; Hosking DJ
Osteoporos Int; 2000; 11(1):52-8. PubMed ID: 10663359
[TBL] [Abstract][Full Text] [Related]
11. Normative calcaneal quantitative ultrasound data as an estimation of skeletal development in Swedish children and adolescents.
Alwis G; Rosengren B; Nilsson JA; Stenevi-Lundgren S; Sundberg M; Sernbo I; Karlsson MK
Calcif Tissue Int; 2010 Dec; 87(6):493-506. PubMed ID: 20960155
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist.
Alessandri SB; Pereira Fde A; Villela RA; Antonini SR; Elias PC; Martinelli CE; Castro Md; Moreira AC; Paula FJ
Clinics (Sao Paulo); 2012; 67(6):591-6. PubMed ID: 22760897
[TBL] [Abstract][Full Text] [Related]
13. Quantitative ultrasound of the calcaneus and dual X-ray absorptiometry of the lumbar spine in assessment and follow-up of skeletal status in patients after kidney transplantation.
Kovac D; Lindic J; Kandus A; Bren FA
Osteoporos Int; 2003 Apr; 14(2):166-70. PubMed ID: 12730786
[TBL] [Abstract][Full Text] [Related]
14. Influence of physical activity on ultrasound and dual-energy X-ray absorptiometry bone measurements in peripubertal girls: a cross-sectional study.
Lehtonen-Veromaa M; Möttönen T; Nuotio I; Heinonen OJ; Viikari J
Calcif Tissue Int; 2000 Apr; 66(4):248-54. PubMed ID: 10742439
[TBL] [Abstract][Full Text] [Related]
15. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.
Frost ML; Blake GM; Fogelman I
J Bone Miner Res; 2001 Feb; 16(2):406-16. PubMed ID: 11204441
[TBL] [Abstract][Full Text] [Related]
16. The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty.
Park HK; Lee HS; Ko JH; Hwang IT; Lim JS; Hwang JS
Clin Endocrinol (Oxf); 2012 Nov; 77(5):743-8. PubMed ID: 22530679
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
Magiakou MA; Manousaki D; Papadaki M; Hadjidakis D; Levidou G; Vakaki M; Papaefstathiou A; Lalioti N; Kanaka-Gantenbein C; Piaditis G; Chrousos GP; Dacou-Voutetakis C
J Clin Endocrinol Metab; 2010 Jan; 95(1):109-17. PubMed ID: 19897682
[TBL] [Abstract][Full Text] [Related]
18. Use of a Gonadotropin-releasing Hormone Analog to Treat Idiopathic Central Precocious Puberty Is Not Associated with Changes in Bone Structure in Postmenarchal Adolescents.
Iannetta R; Melo AS; Iannetta O; Marchini JS; Paula FJ; Martinelli CE; Rosa e Silva AC; Ferriani RA; Martins WP; Reis RM
J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):304-8. PubMed ID: 26081481
[TBL] [Abstract][Full Text] [Related]
19. Does the combination of quantitative ultrasound and dual-energy X-ray absorptiometry improve fracture discrimination?
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 2001; 12(6):471-7. PubMed ID: 11446563
[TBL] [Abstract][Full Text] [Related]
20. Does quantitative ultrasound imaging enhance precision and discrimination?
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 2000; 11(5):425-33. PubMed ID: 10912845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
